Literature DB >> 7483280

K562 cell strains differ in their response to poliovirus infection.

P A Benton1, J W Murphy, R E Lloyd.   

Abstract

Poliovirus readily establishes a persistent infection in the K562-Mu erythroleukemia cell strain. In this study, three additional K562 cell strains were analyzed for their responses to poliovirus infection and found to be quite variable. K562 cells obtained from the ATCC established a persistent infection, similar to the K562-Mu cell strain, while the majority of cells from two other strains, K562-KI and K562-We, were killed by 4 or 11 days postinfection (p.i.), respectively. Several characteristics of the uninfected and infected cell strains were examined to determine if differences existed which could explain the dramatically different responses to infection. Since K562 cell strains can differentiate toward several cell lineages, the four strains were analyzed for physical and functional likeness to the original K562 cell line using well-established functional criteria to determine whether gross changes in differentiation state had occurred. Based on the lack of MHC class I antigen expression and a dose-dependent increase in globin synthesis in response to hemin, all three laboratory K562 cell strains were indistinguishable from the ATCC reference strain. Surface poliovirus receptor levels were also similar in all K562 cell strains, although four- to fivefold lower than those in HeLa cells. Most biochemical events in virus replication either were very similar among K562 cells or were slightly variable and did not correlate with the degree of cell killing. These included levels of virus production, levels of viral protein produced, and processing and turnover of viral polypeptides. The key difference between the cell strains which consistently correlated with cell killing was the degree of virus-induced host translation shutoff, which was always greatest in the most virus-sensitive K562-KI cells. In addition, levels of 2Apro produced in K562 cell strains did not appear to correlate with the levels of host protein shutoff. A related and novel finding in these studies which also strongly correlated with the outcome of infection was the ability of levels of intact p220 to recover by 24 hr p.i. in virus-resistant K562-Mu and -ATCC cells. These data suggest that the key determinants of outcome of infection in this cell model are cytoplasmic host factors related to cytopathology and not factors which may modulate levels of viral protein synthesis or RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483280     DOI: 10.1006/viro.1995.1541

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells.

Authors:  W E Marissen; R E Lloyd
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

2.  Multiple eIF4GI-specific protease activities present in uninfected and poliovirus-infected cells.

Authors:  Miguel Zamora; Wilfred E Marissen; Richard E Lloyd
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation.

Authors:  P A Benton; D J Barrett; R L Matts; R E Lloyd
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Persistent poliovirus infection of human fetal brain cells.

Authors:  N Pavio; M H Buc-Caron; F Colbère-Garapin
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 5.  Behind closed membranes: the secret lives of picornaviruses?

Authors:  Alexsia L Richards; William T Jackson
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

6.  Hematopoietic cancer cell lines can support replication of Sabin poliovirus type 1.

Authors:  Dinja Oosterhoff; Gerard van de Weerd; Gerco van Eikenhorst; Tanja D de Gruijl; Leo A van der Pol; Wilfried A M Bakker
Journal:  Biomed Res Int       Date:  2015-02-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.